These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28754667)

  • 1. 'It's the progression, doctor': what patients with motor neurone disease really are interested in.
    Grosskreutz J
    J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):897. PubMed ID: 28754667
    [No Abstract]   [Full Text] [Related]  

  • 2. Pragmatic approach to muscle MRI biomarkers in motor neuron disease.
    Simon NG
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):230. PubMed ID: 29142141
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis.
    Schweitzer AD; Liu T; Gupta A; Zheng K; Seedial S; Shtilbans A; Shahbazi M; Lange D; Wang Y; Tsiouris AJ
    AJR Am J Roentgenol; 2015 May; 204(5):1086-92. PubMed ID: 25905946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
    Wang S; Melhem ER
    Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis.
    Verstraete E; Veldink JH; Hendrikse J; Schelhaas HJ; van den Heuvel MP; van den Berg LH
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):383-8. PubMed ID: 21965521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigated transcranial magnetic stimulation in amyotrophic lateral sclerosis.
    Chervyakov AV; Bakulin IS; Savitskaya NG; Arkhipov IV; Gavrilov AV; Zakharova MN; Piradov MA
    Muscle Nerve; 2015 Jan; 51(1):125-31. PubMed ID: 25049055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the amyotrophic lateral sclerosis and motor neurone disease community in health-care resourcing.
    Levvy G
    Int J Clin Pract Suppl; 1998 Apr; 93():14-7. PubMed ID: 9691245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences of burden, needs, rewards and resilience in family caregivers of people living with Motor Neurone Disease/Amyotrophic Lateral Sclerosis: A secondary thematic analysis of qualitative interviews.
    Weisser FB; Bristowe K; Jackson D
    Palliat Med; 2015 Sep; 29(8):737-45. PubMed ID: 25762578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living with amyotrophic lateral sclerosis/motor neurone disease (ALS/MND): decision-making about 'ongoing change and adaptation'.
    King SJ; Duke MM; O'Connor BA
    J Clin Nurs; 2009 Mar; 18(5):745-54. PubMed ID: 19239541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
    Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
    J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural MRI correlates of amyotrophic lateral sclerosis progression.
    Senda J; Atsuta N; Watanabe H; Bagarinao E; Imai K; Yokoi D; Riku Y; Masuda M; Nakamura R; Watanabe H; Ito M; Katsuno M; Naganawa S; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):901-907. PubMed ID: 28501822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of corticospinal tract (CST) fibers in UMN-predominant ALS patients with or without CST hyperintensity: A diffusion tensor tractography study.
    Rajagopalan V; Pioro EP
    Neuroimage Clin; 2017; 14():574-579. PubMed ID: 28337412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
    Edwards IR; Star K; Kiuru A
    Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper motor neuron and extra-motor neuron involvement in amyotrophic lateral sclerosis: a clinical and brain imaging review.
    van der Graaff MM; de Jong JM; Baas F; de Visser M
    Neuromuscul Disord; 2009 Jan; 19(1):53-8. PubMed ID: 19070491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia.
    Shahrizaila N; Sobue G; Kuwabara S; Kim SH; Birks C; Fan DS; Bae JS; Hu CJ; Gourie-Devi M; Noto Y; Shibuya K; Goh KJ; Kaji R; Tsai CP; Cui L; Talman P; Henderson RD; Vucic S; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):821-30. PubMed ID: 27093948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor neuron disease: Proinflammatory monocytes might contribute to ALS progression.
    Fyfe I
    Nat Rev Neurol; 2017 Jul; 13(7):385. PubMed ID: 28497803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.